LUIS ALBERTO
MENCHÉN VISO
Profesor asociado de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (48)
2024
-
Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus
BMJ Open Gastroenterology, Vol. 11, Núm. 1
2023
-
Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice
Frontiers in Microbiology, Vol. 13
-
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Journal of Clinical Medicine, Vol. 12, Núm. 14
-
Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease
Biomedicine and Pharmacotherapy, Vol. 159
-
Transmural or mucosal healing in Crohn´s disease. Which is the goal to be pursued?
Revista espanola de enfermedades digestivas, Vol. 115, Núm. 6, pp. 289-291
2022
-
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare
Frontiers in Immunology, Vol. 13
-
Lentinula edodes extract increases goblet cell number and Muc2 expression in an intestinal inflammatory model of Trichinella spiralis infection
Biomedicine and Pharmacotherapy, Vol. 150
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels
Alimentary Pharmacology and Therapeutics, Vol. 54, Núm. 8, pp. 999-1012
2020
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596
2019
-
Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study
Digestive and Liver Disease, Vol. 51, Núm. 5, pp. 669-674
-
Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn’s disease patients: the Practicrohn study
Expert Review of Gastroenterology and Hepatology, Vol. 13, Núm. 8, pp. 807-813
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12
-
Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain
Therapeutic Advances in Gastroenterology, Vol. 12
-
Transition Care Program of Adolescents With Inflammatory Bowel Disease: Perceptions From A Survey for Patients
Inflammatory bowel diseases, Vol. 25, Núm. 3, pp. e22-e23
2018
-
Reviewing the therapeutic role of budesonide in Crohn's disease
Gastroenterologia y Hepatologia
2016
-
Etiopatogenia: nexos en común entre la hidradenitis supurativa y la enfermedad de Crohn
Actas Dermo-Sifiliograficas, Vol. 107, pp. 13-20
2015
-
A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease
American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 308, Núm. 12, pp. 981-993
-
Incidence, management, and course of cancer in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 9, Núm. 4, pp. 326-333
-
Weber-Christian disease with ileocolonic involvement successfully treated with infliximab
World Journal of Gastroenterology, Vol. 21, Núm. 17, pp. 5417-5420